Health

Lupin rolls out generic oncology drug in US market

February 2, 2026 0 views 1 min read
Lupin rolls out generic oncology drug in US market
Drug firm Lupin has launched a generic cancer treatment medication in the US. The company introduced Dasatinib Tablets in various strengths. This product is bioequivalent to Sprycel Tablets. It is indicated for adults with Philadelphia chromosome-positive chronic myeloid leukemia. The US market for Dasatinib Tablets had significant sales.

Tags